Colgate-Palmolive’s premium strategy and pet nutrition expansion drive growth, with a $115 target signaling 26% upside. Read more about CL stock here.

JPMorgan analyst Andrea Teixeira raised the firm’s price target on Colgate-Palmolive (CL) to $99 from $97 and keeps an Overweight rating on the ...

CL benefits from robust pricing and productivity initiatives. The company's innovation strategy also bodes well.

We recently published a list of Jim Cramer Discusses These 12 Stocks & Says Mag 7 Stocks Are A Thing Of The Past. In this ...

Colgate-Palmolive has been taking a “full funnel mindset” approach to retail media by restructuring its marketing teams and ...

Bearish flow noted in Colgate Palmolive with 1,369 puts trading, or 1.2x expected. Most active are 3/14 weekly 95 puts and 3/28 weekly 91 puts, ...

Colgate-Palmolive (NYSE:CL – Get Free Report) has been assigned an average rating of “Hold” from the twenty-one analysts that ...

Colgate-Palmolive Company ( NYSE: CL) UBS Global Consumer and Retail Conference Call March 12, 2025 3:00 PM ET John Faucher - Chief Investor Relations Officer and EVP, M&A ...

As such, the narrative for safe stocks to buy — or public companies with boring but reliable businesses — has shot to the ...

Investors in Colgate-Palmolive Co. (Symbol: CL) saw new options begin trading today, for the June 2026 expiration. One of the key data points that goes into the price an option buyer is willing to ...